1. Home
  2. DIBS vs VYGR Comparison

DIBS vs VYGR Comparison

Compare DIBS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1stdibs.com Inc.

DIBS

1stdibs.com Inc.

HOLD

Current Price

$5.06

Market Cap

201.7M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.49

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIBS
VYGR
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.7M
222.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DIBS
VYGR
Price
$5.06
$3.49
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$17.00
AVG Volume (30 Days)
211.7K
631.7K
Earning Date
02-27-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$89,422,000.00
$31,316,000.00
Revenue This Year
$3.73
N/A
Revenue Next Year
$2.21
$71.77
P/E Ratio
N/A
N/A
Revenue Growth
3.49
N/A
52 Week Low
$2.30
$2.65
52 Week High
$6.63
$5.55

Technical Indicators

Market Signals
Indicator
DIBS
VYGR
Relative Strength Index (RSI) 31.47 37.23
Support Level $5.29 $3.36
Resistance Level $5.60 $3.91
Average True Range (ATR) 0.26 0.23
MACD -0.04 -0.04
Stochastic Oscillator 12.79 18.75

Price Performance

Historical Comparison
DIBS
VYGR

About DIBS 1stdibs.com Inc.

1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: